Local delivery of a tissue factor antibody reduces early leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts

被引:15
作者
Annex, BH [1 ]
Davies, MG
Fulton, GJ
Huynh, TTT
Channon, KM
Ezekowitz, MD
Hagen, PO
机构
[1] Duke Univ, Med Ctr, Durham VA Med Ctr, Dept Med Cardiol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Durham VA Med Ctr, Dept Surg, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Durham VA Med Ctr, Atherosclerosis & Vasc Biol Res Lab, Durham, NC 27710 USA
[4] Yale Univ, Dept Med, Div Cardiovasc, New Haven, CT 06520 USA
关键词
Tissue Factor; vein graft; intimal hyperplasia;
D O I
10.1006/jsre.1998.5438
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Tissue Factor-mediated thrombin generation involves the generation of VIIa and X-a and has been implicated in the pathogenesis of intimal hyperplasia, In experimental vein grafts, Tissue Factor protein is increased over the first 3 days and colocalized with CD18-positive leukocytes; this increase in Tissue Factor precedes the development of intimal hyperplasia, This study further evaluates the potential role of Tissue Factor in vein graft intimal hyperplasia by directly inhibiting Tissue Factor protein, Methods. New Zealand white rabbits underwent interpositional bypass grafting of the common carotid artery using the external jugular vein, Perioperatively, murine anti-rabbit Tissue Factor antibody (109 mu g/ml gel, 12,500x IC50 of Tissue Factor activity) was applied to the adventitial surface of the graft, using a pluronic gel (30% soln,). Tissue Factor antibody treated vein grafts were compared to control and empty gel-treated vein grafts. Vein grafts were examined at 3 days to assess CD18-positive leukocyte infiltration and the presence of residual antibody by Western blotting. At 28 days, intimal and medial dimensions were quantified using videomorphometry. Results. At day 3, there was marked reduction in CD18-positive leukocytes in the Tissue Factor antibody versus control vein grafts (6.3 +/- 4.7 vs 20.8 +/- 7.4 per 200x field, P < 0.05). At 28 days, intimal hyperplasia was similar for the control (70 +/- 4 mu m, mean +/- SEM), gel (73 +/- 4 mu m), and Tissue Factor antibody (75 +/- 4 mu m) vein grafts. However, medial thickness (76 +- 4 mu m;, P < 0.05) was significantly increased compared to the gel treated vein graft (61 +/- 5 mu m). Conclusion. Local delivery of pharmacologic doses of an anti-rabbit Tissue Factor antibody decreased CD18-positive leukocyte infiltration but failed to limit intimal hyperplasia in experimental vein grafts. The results suggest that inhibition of Tissue Factor protein modulates polymorphonuclear leukocyte-endothelial interactions but not in the subsequent development of intimal hyperplasia, It implies that the relationship between the extrinsic coagulation cascade and intimal hyperplasia in vein grafts is complex. (C) 1998 Academic Press.
引用
收藏
页码:164 / 170
页数:7
相关论文
共 32 条
[1]   TISSUE FACTOR PROMOTES MELANOMA METASTASIS BY A PATHWAY INDEPENDENT OF BLOOD-COAGULATION [J].
BROMBERG, ME ;
KONIGSBERG, WH ;
MADISON, JF ;
PAWASHE, A ;
GAREN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) :8205-8209
[2]  
Brown DM, 1996, ARCH SURG-CHICAGO, V131, P1086
[3]   THE ROLE OF TISSUE FACTOR IN THE PRODUCTION OF THROMBIN [J].
CARSON, SD ;
BROZNA, JP .
BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (02) :281-292
[4]   Modulation of tissue factor protein expression in experimental venous bypass grafts [J].
Channon, KM ;
Fulton, GJ ;
Davies, MG ;
Peters, KG ;
Ezekowitz, MD ;
Hagen, PO ;
Annex, BH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (07) :1313-1319
[5]  
COX JL, 1991, PROG CARDIOVASC DIS, V34, P455
[6]   THE INTEGRITY OF EXPERIMENTAL VEIN GRAFT ENDOTHELIUM - IMPLICATIONS ON THE ETIOLOGY OF EARLY GRAFT FAILURE [J].
DAVIES, MG ;
KLYACHKIN, ML ;
DALEN, H ;
MASSEY, MF ;
SVENDSEN, E ;
HAGEN, PO .
EUROPEAN JOURNAL OF VASCULAR SURGERY, 1993, 7 (02) :156-165
[7]   PATHOBIOLOGY OF INTIMAL HYPERPLASIA [J].
DAVIES, MG ;
HAGEN, PO .
BRITISH JOURNAL OF SURGERY, 1994, 81 (09) :1254-1269
[8]   PATHOPHYSIOLOGY OF VEIN GRAFT FAILURE - A REVIEW [J].
DAVIES, MG ;
HAGEN, PO .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1995, 9 (01) :7-18
[9]  
DAVIES MG, 1994, EUR J VASCULAR SURG, V8, P156
[10]  
DRAKE WT, 1992, LAB INVEST, V67, P617